Healthcare provider profile · identity verified

Nicholas Patrick Masyga, D.O.

Family Practice · HAMBURG, NY · NPI 1033556972

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	413	135
Lisinopril	Lisinopril	373	127
Levothyroxine Sodium	Levothyroxine Sodium	288	88
Omeprazole	Omeprazole	215	67
Metformin Hcl	Metformin Hcl	212	66
Ozempic	Semaglutide	211	33
Amlodipine Besylate	Amlodipine Besylate	210	73
Rosuvastatin Calcium	Rosuvastatin Calcium	202	69
Metoprolol Succinate	Metoprolol Succinate	194	67
Hydrochlorothiazide	Hydrochlorothiazide	171	54
Trazodone Hcl	Trazodone Hcl	169	53
Albuterol Sulfate Hfa	Albuterol Sulfate	156	46
Losartan Potassium	Losartan Potassium	143	47
Furosemide	Furosemide	139	49
Pantoprazole Sodium	Pantoprazole Sodium	129	42
Prednisone	Prednisone	126	99
Gabapentin	Gabapentin	114	46
Simvastatin	Simvastatin	114	32
Tamsulosin Hcl	Tamsulosin Hcl	110	37
Famotidine	Famotidine	104	32
Ibuprofen	Ibuprofen	94	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	92	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	14
Meloxicam	Meloxicam	81	18
Metoprolol Tartrate	Metoprolol Tartrate	78	23
Allopurinol	Allopurinol	74	20
Fluticasone Propionate	Fluticasone Propionate	66	22
Zolpidem Tartrate	Zolpidem Tartrate	64	11
Eliquis	Apixaban	60	23
Metformin Hcl Er	Metformin Hcl	58	20
Pioglitazone Hcl	Pioglitazone Hcl	57	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	56	43
Bupropion Xl	Bupropion Hcl	56	18
Fluoxetine Hcl	Fluoxetine Hcl	54	12
Carvedilol	Carvedilol	53	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	11
Clopidogrel	Clopidogrel Bisulfate	52	17
Pravastatin Sodium	Pravastatin Sodium	52	19
Buspirone Hcl	Buspirone Hcl	50	17
Citalopram Hbr	Citalopram Hydrobromide	49	18
Pregabalin	Pregabalin	46	suppressed
Tramadol Hcl	Tramadol Hcl	45	13
Alprazolam	Alprazolam	44	19
Fluconazole	Fluconazole	44	16
Alendronate Sodium	Alendronate Sodium	43	11
Potassium Chloride	Potassium Chloride	42	16
Glipizide	Glipizide	41	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	14
Duloxetine Hcl	Duloxetine Hcl	40	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	12
Acetaminophen-Codeine	Acetaminophen With Codeine	38	12
Irbesartan	Irbesartan	38	suppressed
Spironolactone	Spironolactone	38	13
Lovastatin	Lovastatin	36	suppressed
Azithromycin	Azithromycin	35	29
Jardiance	Empagliflozin	35	12
Synthroid	Levothyroxine Sodium	34	11
Xarelto	Rivaroxaban	34	suppressed
Atenolol	Atenolol	32	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Glimepiride	Glimepiride	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Sertraline Hcl	Sertraline Hcl	28	suppressed
Ezetimibe	Ezetimibe	27	13
Donepezil Hcl	Donepezil Hcl	26	11
Warfarin Sodium	Warfarin Sodium	26	suppressed
Cephalexin	Cephalexin	25	21
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Amoxicillin	Amoxicillin	22	15
Enalapril Maleate	Enalapril Maleate	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	19
Rybelsus	Semaglutide	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Nystatin	Nystatin	17	11
Fenofibrate	Fenofibrate,micronized	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	12
Bumetanide	Bumetanide	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Icosapent Ethyl	Icosapent Ethyl	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Naproxen	Naproxen	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Levofloxacin	Levofloxacin	12	11
Synjardy Xr	Empagliflozin/Metformin Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Valsartan	Valsartan	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Clonidine	Clonidine	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error